Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127361451 | 12736145 | 1 | I | 201207 | 20160908 | 20160913 | 20160913 | EXP | BE-ROCHE-1828455 | ROCHE | 70.80 | YR | F | Y | 66.00000 | KG | 20160913 | MD | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127361451 | 12736145 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 127361451 | 12736145 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 127361451 | 12736145 | 3 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | Unknown | U | 0 | ||||||||||
| 127361451 | 12736145 | 4 | C | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | 0 | /month | ||||||||||
| 127361451 | 12736145 | 5 | C | PANTOMED (BELGIUM) | 2 | Unknown | 0 | 20 | MG | QD | |||||||||
| 127361451 | 12736145 | 6 | C | LYRICA | PREGABALIN | 1 | Unknown | 0 | 150 | MG | BID | ||||||||
| 127361451 | 12736145 | 7 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | EVERY MON-WED-FRI | 0 | 250 | MG | TIW | |||||||
| 127361451 | 12736145 | 8 | C | ZOVIRAX | ACYCLOVIR | 1 | Unknown | 0 | 800 | MG | QD | ||||||||
| 127361451 | 12736145 | 9 | C | TRANSTEC | BUPRENORPHINE | 1 | Unknown | 3/4 PER 72 H | 0 | 35 | UG | ||||||||
| 127361451 | 12736145 | 10 | C | TEMGESIC | BUPRENORPHINE HYDROCHLORIDE | 1 | Sublingual | 0 | |||||||||||
| 127361451 | 12736145 | 11 | C | XANAX | ALPRAZOLAM | 1 | Unknown | WHEN NEEDED | 0 | .5 | MG | ||||||||
| 127361451 | 12736145 | 12 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | 1 HOUR BEFORE START RADIOTHERAPY | 0 | 8 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127361451 | 12736145 | 1 | Waldenstrom's macroglobulinaemia |
| 127361451 | 12736145 | 3 | Waldenstrom's macroglobulinaemia |
| 127361451 | 12736145 | 9 | Pain |
| 127361451 | 12736145 | 10 | Pain |
| 127361451 | 12736145 | 11 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127361451 | 12736145 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127361451 | 12736145 | Off label use | |
| 127361451 | 12736145 | Polyneuropathy | |
| 127361451 | 12736145 | Respiratory tract infection | |
| 127361451 | 12736145 | Waldenstrom's macroglobulinaemia recurrent |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127361451 | 12736145 | 1 | 201207 | 0 | ||
| 127361451 | 12736145 | 2 | 201212 | 0 | ||
| 127361451 | 12736145 | 3 | 201205 | 0 |